Novita Healthcare

What Novita Healthcare does

Novita Healthcare is an India-based multinational pharmaceutical company founded in 1984, operated across three generations of the Bankda family and currently led by directors Prateek Bankda and Pranav Bankda. The company manufactures and markets branded generic and over-the-counter (OTC) medicines across both Allopathic and Ayurvedic streams, spanning therapeutic categories such as pain management, anti-allergic, antibiotics and wellness. Its product portfolio covers a wide range of dosage forms — tablets, capsules, soft gels, powders, ointments, sprays, oral liquids, eye/ear drops, dry powder and liquid injectables, sachets, effervescent tablets, candies, gummies — and consumer brands including CTZ (positioned as India's #1 selling Cetirizine brand), FASTAC (leading pain management brand with a super-fast dissolving formula), Vigromen (condoms and vitality), Gripe Water, Narisudha, and a recent line of wellness supplements (Liver Detox, Female Health, Boost Digestion, Remove Addiction).

The company runs an asset-light operating model, relying on 30+ handpicked third-party contract manufacturers that are GMP-compliant (with WHO GMP compliance for export-oriented units) rather than operating its own plants. It supplies products across 250+ Indian cities through a 400+ strong dedicated sales team with direct reach to 250,000+ chemists, augmented by 50+ distributors and 4,000+ stockists, and exports finished dosage forms, APIs, excipients and packaging materials to 10+ countries across Africa, South East Asia and Central Asia with dossiers in ACTD and CTD formats.

Revenue is generated almost entirely through one-time sales of pharmaceutical, consumer healthcare, FMCG and export products across offline chemist channels and a nascent DTC e-commerce layer via SmartBiz and branded microsites. Pricing is not publicly disclosed. Headcount is concentrated in a 400+ India field-sales organization, with additional operational support based in Mumbai (headquarters) and Indore (operations and manufacturing support). The company is privately held, with no disclosed external investors, funding rounds, M&A activity, or regulatory actions.

Name

Novita Healthcare

Legal name

Novita Healthcare

Website

https://novitahealthcare.in

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

101–250 employees

Short description

Novita Healthcare is a privately held Indian pharmaceutical company that manufactures and markets branded generic and OTC medicines — including CTZ, FASTAC and Vigromen — distributed through 250,000+ chemists across India and exported to 10+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYCRAOAHAB

OTC Medicines & Consumer Health Products Distribution

Consumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale Distribution

SECONDARYHLAIAJAC

OTC & Consumer Health Distributors

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

SECONDARYCRAOAHAE

Medical Supplies & Consumables Wholesale (Non-Device)

Consumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale Distribution

SECONDARYHLAIAJAO

Compounding Ingredient & API Distributors (Pharma Supply)

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

• Pharmaceutical manufacturing
• OTC consumer healthcare
• Allopathic ayurvedic medicines
• Condom consumer products
• Dietary wellness supplements

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Revenue model

1. Pharmaceutical Products Sales: Manufacturing and supplying high-quality medicines including Tablets, Capsules, SoftGel, Powders, Ointments, Sprays, Oral Liquids, Eye/Ear Drops, Dry Powder Injectables, Liquid Injectables in Ampoules and Vials, Sachets, Effervescent Tablets
2. Consumer Healthcare Products: OTC medicines (Fastac, CTZ, Gripe Water, Narisudha, Vigromen) and wellness products sold through retail and e-commerce channels
3. Export Products: Export of pharmaceutical finished dosage forms, API and excipients, packaging materials to 10+ countries
4. FMCG Products: Confectionaries, Food & Wellness Products, Food Grains and Commodities

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Novita Healthcare manufactures and supplies a wide range of pharmaceutical finished dosage forms (tablets, capsules, soft gels, ointments, sprays, oral liquids, injectables, sachets, effervescent tablets) in both Allopathic and Ayurvedic streams, along with branded OTC consumer products (CTZ, FASTAC, Gripe Water, Narisudha), Vigromen condoms, and dietary wellness supplements. The company distributes through a 400+ strong sales team to 250,000+ chemists domestically and exports to 10+ countries.

Product overview

Novita Healthcare is a multinational pharmaceutical company manufacturing and supplying high-quality medicines and wellness products across India and 10+ countries. The company operates multiple divisions including Pharmaceuticals (Finished Dosage Forms, API, Excipients, Packaging Materials), Confectionaries, and Food & Wellness Products. Core brands include CTZ (India's #1 Cetirizine brand for allergies), FASTAC (leading pain management brand), Vigromen (condoms and vitality products), and various OTC products like Gripe Water and Narisudha. The company produces a wide range of dosage forms including Tablets, Capsules, SoftGels, Powders, Ointments, Sprays, Oral Liquids, Eye/Ear Drops, Injectables, Sachets, Effervescent Tablets, Candies, and Gummies. Domestic operations include three divisions with reach to 250,000+ chemists through a 400+ sales team, while exports cover Africa, South East Asia, and Central Asia.

Differentiator

Problem solved

Functional benefit

Brands

• CTZ: India's Most Trusted and Largest Selling Cetirizine Brand for cough, cold and allergies. Number 1 selling Cetirizine brand in India with PAN India reach.
• FASTAC
• Vigromen

Products and services

• CTZ

Quantifiable outcome

• CTZ is the number 1 selling Cetirizine brand in India with PAN India reach
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• 30+ Manufacturing SitescoreOthersCompany has partnered with over 30 carefully handpicked manufacturing sites to ensure best and highest quality and timely supplies. All sites are GMP Compliant and export oriented units are WHO GMP Compliant.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Torrent Pharmaceuticals: Large Indian pharmaceutical company with a strong domestic branded generics franchise across multiple therapeutic categories and emerging-market export presence, relevant to Novita's branded pharma and export business model.
• Dabur India: Leading Indian FMCG and Ayurvedic/OTC healthcare company with an extensive PAN India distribution network and a broad consumer health product range, directly comparable to Novita's ayurvedic and OTC consumer health positioning and distribution scale.
• Cadila Pharmaceuticals (Zydus Cadila): Major Indian pharmaceutical group with a broad branded generics portfolio across multiple therapeutic categories and a large domestic field force, directly relevant to the chemist-channel branded pharma model that Novita operates.
• Emami Limited: Large Indian consumer health and FMCG company with a strong mass-market OTC and personal care portfolio (e.g., Zandu, Boroplus). It is a relevant comparable for Novita's push into consumer health, wellness supplements and OTC consumer brands.
• Cipla: One of India's largest listed pharmaceutical companies with a broad branded generics, OTC and API portfolio spanning domestic and emerging markets. It competes with Novita in several of the same OTC categories and exports to overlapping geographies, making it a broad incumbent reference point.
• Lupin Limited: Major Indian pharmaceutical company with a sizable branded domestic portfolio across multiple therapeutic areas including anti-allergics and pain management, where it competes head-on with Novita's CTZ and FASTAC brands.

Direct peers

• Mankind Pharma: India's leading OTC-focused pharmaceutical company with a comparable portfolio of mass-market consumer health brands (e.g., Moxikind, Manforce condoms) and a deeply entrenched chemist distribution model across India, making it the closest direct comparable to Novita's CTZ/FASTAC/Vigromen franchise.
• Alkem Laboratories: Indian pharmaceutical company with a strong domestic branded generics and OTC franchise across multiple therapeutic categories and a similarly broad PAN India distribution network, closely mirroring Novita's branded-pharma-driven business model.
• HLL Lifecare Limited: Indian government-owned manufacturer and marketer of consumer health products including the Moods condom brand, directly comparable to Novita's Vigromen condom portfolio in terms of category, channel, and consumer positioning in India.
• TTK Healthcare: India-based healthcare company spanning OTC pharmaceuticals, consumer health products, and consumer goods (including condoms and wellness), with a comparable mix of branded pharma and consumer health offerings relevant to Novita's CTZ, FASTAC and Vigromen product lines.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Novita_Health
• Facebookfacebook.com/novitahealthcare
• LinkedInlinkedin.com/company/novitahealthcare

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novita Healthcare